Loading...
GlucoTrack Inc (GCTK) is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, absence of significant trading trends, no recent news catalysts, and bearish technical indicators suggest that the stock does not currently present a compelling investment opportunity.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 44.929, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.598, with resistance levels at 1.717 and 1.79, and support levels at 1.48 and 1.407. Overall, the technical indicators do not strongly support a buy signal.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
The company reported negative financial performance in Q3 2025, with a YoY decline in net income (-18.01%) and EPS (-99.57%). The stock also lacks significant trading trends or positive sentiment from insiders or hedge funds.
In Q3 2025, the company reported zero revenue growth (0.00% YoY), a net income drop to -$4,171,000 (-18.01% YoY), and an EPS decline to -4.64 (-99.57% YoY). Gross margin remained at 0, showing no improvement.
No data available for analyst ratings or price target changes.
